Hypertrophic cardiomyopathy: open trials in Poland

• NCT07023614

  A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

  Trial Treatment · Phase 2 · Imbria Pharmaceuticals, Inc.

  Katowice · Warsaw · Wroclaw

  Registry updated 2026-10-26

• 2024-515125-28-00

  A randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy

  Trial Treatment · Phase 2 · Imbria Pharmaceuticals Inc.

  Kardio Brynów Sp. z o.o., Katowice · Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych i Administracji, Warsaw · 4 Wojskowy Szpital Kliniczny Z Poliklinika Samodzielny Publiczny Zaklad Opieki Zdrowotnej We Wroclaw, Wrocław

  Registry updated 2026-10-19

• NCT04848506

  Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM

  Trial Treatment · Phase 2/3 · Cytokinetics

  Kardio Brynów Sp. z o.o., Katowice · Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy, Warsaw

  Registry updated 2026-10-13

• NCT05489705

  A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

  Research · Bristol-Myers Squibb

  Katowice · Warsaw

  Registry updated 2026-08-19

• NCT06555237

  MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies

  Trial Treatment · Phase 2 · Medical University of Warsaw

  Department of Paediatrics, The Medical University of Warsaw, Poland, Warsaw

  Registry updated 2024-08-15

All Hypertrophic cardiomyopathy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error